The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Amgen Inc. (NASDAQ:AMGN) for the period of 9-Day stands at 72.83% while the stochastic %D for the same period stands at 59.14%.
The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Amgen Inc. (NASDAQ:AMGN) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.
Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for Amgen Inc. (NASDAQ:AMGN) while 20-100 Day MACD Oscillator indicates “Sell”.
Bollinger band is a volatility indicator of a certain security, currently Amgen Inc. (NASDAQ:AMGN)’s 20-Day Bollinger Band indicates “Hold”.
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science’s promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives.
Previous Day Activity Analysis
On the last trading day, Amgen Inc. (NASDAQ:AMGN) opened the session at $171.8 and after going down -0.42% closed at $172.41. The stock gained 0.61 points in the last trade.
Amgen Inc. (NASDAQ:AMGN)’s stock fluctuated in the range of $171.60 and $174.07 during the previous active session. Amgen Inc. (NASDAQ:AMGN) traded with the volume of 2.58 Million with average volume of 5.35 Million. The stock has MEDIUM volatility on the last trading session.
Currently the Beta for the company remains at 1.36 while ATR (Average True Range) and RSI (Relative Strength Index) are at 4.69 and 46.12 respectively.
Currently the Insider Ownership of the shares of Amgen Inc. (NASDAQ:AMGN) is at 0.1% and the shares outstanding are 737.1 Million.
Important Ratio Analysis
Some important ratios to consider here for Amgen Inc. (NASDAQ:AMGN) are discussed below:
Dividend yield of Amgen Inc. (NASDAQ:AMGN) stands at 3.06% whereas Price to Earnings P/E ratio stands at 15.68 while Forward P/E shows the value of 12.22.
The PEG ratio (Price to Earning to Growth) emits the value of 3.73. The Price to Sale P/S and Price to Book P/B shows the value of 5.56 and 4.95 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 3.05 and 17.78 correspondingly.
The Quick Ratio of Amgen Inc. (NASDAQ:AMGN) stands at 5.2 while the Current Ratio depicts the value of 5.5.
Return on Assets ROA of Amgen Inc. (NASDAQ:AMGN) is at 2.5% whereas, Return on Equity ROE and Return of Investment ROI of Amgen Inc. (NASDAQ:AMGN) stand at 6.6% and 14% respectively.
The payout ratio of Amgen Inc. (NASDAQ:AMGN) stands at 174.6%.
Stock Performance Analysis b>
The stock performance of Amgen Inc. (NASDAQ:AMGN) on the basis of 5 day trade show the dip of -0.64% whereas, the monthly performance of the stock shows decrease of -8.92%.
The quarterly performance of the stock remained in red zone with the value of -5.98% while six month performance of the shares of Amgen Inc. (NASDAQ:AMGN) remained bearish with the count of -7.04%.
The yearly and YTD performance of Amgen Inc. (NASDAQ:AMGN) remained mix at 5.91% and -0.86% respectively.